IRIS
BRILLANTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.237
EU - Europa 2.039
AS - Asia 331
SA - Sud America 3
AN - Antartide 1
Totale 5.611
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.216
GB - Regno Unito 677
IE - Irlanda 529
CN - Cina 246
IT - Italia 227
FR - Francia 203
UA - Ucraina 137
SE - Svezia 117
FI - Finlandia 42
DE - Germania 41
SG - Singapore 30
RU - Federazione Russa 23
CA - Canada 19
TR - Turchia 19
VN - Vietnam 19
BE - Belgio 11
ES - Italia 7
IR - Iran 7
CH - Svizzera 5
PT - Portogallo 5
BD - Bangladesh 2
BR - Brasile 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
HR - Croazia 2
JP - Giappone 2
MX - Messico 2
NL - Olanda 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
DK - Danimarca 1
GS - Georgia del Sud e Isole Sandwich Australi 1
ID - Indonesia 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
PE - Perù 1
PL - Polonia 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 5.611
Salva come PNG Salva come JPEG
Città #
Southend 638
Fairfield 581
Dublin 523
Ashburn 324
Chandler 324
Woodbridge 269
Seattle 232
Wilmington 203
Cambridge 200
Jacksonville 175
Houston 173
Princeton 132
Ann Arbor 107
Siena 68
Beijing 59
Nanjing 49
Helsinki 40
San Mateo 36
San Diego 35
Boardman 25
Moscow 23
Paris 21
Shanghai 21
Dong Ket 18
Dearborn 17
Izmir 17
London 16
Hebei 15
Singapore 13
Florence 11
Rome 11
Shenyang 11
Milan 10
Brussels 9
Nanchang 9
Jiaxing 8
New York 8
Tianjin 8
Changsha 7
Norwalk 7
Isfahan 6
Lambeth 6
San Francisco 6
Chur 5
Fremont 5
Naples 5
Palermo 5
Toronto 5
Turin 5
Waterloo 5
Bari 4
Haikou 4
Kunming 4
Lanzhou 4
Somma Vesuviana 4
Falconara Marittima 3
Jinan 3
Monte San Pietro 3
Ottawa 3
Padova 3
Porto 3
Ypsilanti 3
Asciano 2
Aulla 2
Bologna 2
Brasília 2
Calenzano 2
Casaleone 2
Castrop-rauxel 2
Chieti 2
Chiswick 2
Cormano 2
Dhaka 2
Duncan 2
Empoli 2
Falkenstein 2
Frosinone 2
Hounslow 2
Jersey City 2
Kilburn 2
Kortrijk 2
Lappeenranta 2
Lisbon 2
Madrid 2
Mission Viejo 2
Modena 2
Monopoli 2
Munich 2
Málaga 2
Ningbo 2
Northampton 2
Nuremberg 2
Phoenix 2
Rometta Marea 2
Russell 2
San Damiano al Colle 2
Scandicci 2
Tokyo 2
Vancouver 2
Verona 2
Totale 4.623
Salva come PNG Salva come JPEG
Nome #
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 203
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 191
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 181
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum 172
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 169
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 151
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 146
Distribution of three major hepatitis C virus genotypes in Italy. A multicentre study of 49 5 patients with chronic hepatitis C 138
Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non‐A, non‐B hepatitis 133
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 128
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pylori in dyspeptic patients 126
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 117
Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation 116
HEPATITIS-C VIRUS - A POSSIBLE CAUSE OF CHRONIC HEPATITIS IN ALCOHOLICS 105
Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? 105
Peginterferon-based therapy for chronic hepatitis C virus infection in patients with normal alanine aminotransferase levels 105
Persistent hepatitis C viraemia without liver disease 103
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 102
HCV INFECTION AND CHRONIC ACTIVE HEPATITIS IN ALCOHOLICS 102
Ribavirin for chronic hepatitis C: And the mystery goes on 102
Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests 102
Effect of α‐interferon therapy on hepatitis C viraemia in community‐acquired chronic non‐A, non‐B hepatitis: A quantitative polymerase chain reaction study 101
Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C 100
A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C 100
A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy 98
LONG-TERM PERSISTENCE OF IGM ANTIBODIES TO HCV IN CHRONIC HEPATITIS-C 95
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 94
Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C 93
Reactivation of Crohn's disease after pandemic aH1N1 and seasonal flu vaccinations 93
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3 92
Role of amantadine and other adjuvant therapies in the treatment of hepatitis C 90
Serum IgM antibodies to hepatitis C virus in acute and chronic hepatitis C 89
Severe acute autoimmune hepatitis after natalizumab treatment 88
Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C 86
Serological and histological aspects of hepatitis C virus infection in alcoholic patients 86
Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?” 85
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 83
What hides behind an intention-to-treat analysis? 82
Primary Biliary cholangitis case-finding: an italian multicenter observational study on patients with incidental finding of anti-mithocondrial antibodies 80
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 80
Proctosigmoidite ulcerosa refrattaria e recidivante alla terapia topica trattata con beclometasone dipropionato orale 75
Cell renewal and cancer risk of the stomach: Analysis of cell proliferation kinetics in atrophic gastritis 72
Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis 71
EFFECT OF LACTOBACILLUS ACIDOPHILUS AND BIFIDOBACTERIUM BIFIDUM ON RECTAL CELL-KINETICS AND FECAL PH 66
Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience 66
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis 62
Reversibility of gastrointestinal motor abnormalities in chronic intestinal pseudo-obstruction 59
Incidental findings of anti-mitochondrial antibodies without evidence of Primary Biliary Cholangitis. 56
Whipple's disease with melaena and multiple petechial haemorrhages in duodenal mucosa 53
Re-treatment of patients with chronic hepatitis C in clinical practice: Results of a multicenter retrospective survey [Ritrattamento dei pazienti con epatite cronica da HCV nella pratica clinica: Risultati di uno studio multicentrico retrospettivo] 51
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 51
Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders 48
Enhanced response to peginterferon-alpha-2a based triple therapy in previously non-responsive chronic hepatitis C: Final results of PRETTY study 45
RECTAL CELL-PROLIFERATION AND COLON CANCER RISK IN ULCERATIVE-COLITIS 40
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C 40
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 39
Three-year follow-up of chronic hepatitis C patients treated with ribavirin plus interferon-alfa combination therapy: Evidence for long-term efficacy and safety 35
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues—A Delphi Consensus Project 26
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 26
Trattamento della Epatite da HCV 25
VIROLOGICAL FAILURES TO NEW DIRECT ACTING ANTIVIRALS IN A REAL LIFE SETTING MAY REQUIRE UNCONVENTIONAL REGIMENS FOR RE-TREATMENT 23
Management of Delta Hepatitis 45 years after the discovery of HDV 22
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 22
Loss and seroconversion of hepatitis B surface antigen after vaccine therapy in chronic hepatitis B patients treated with nucleoside/nucleotide analogues 22
Prospective evaluation of aberrant p16 methylation in serum of patients before and after therapy for localized HCC 21
Terapia cellulare in Epatologia 21
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 20
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 19
RIBAVIRIN PRIMING ENHANCES EFFICACY OF CHRONIC HEPATITIS C RE-TREATMENT IN PATIENTS WHO HAD NOT RESPONDED TO PREVIOUS COMBINATION THERAPY 18
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy 18
Incidental finding of anti-mitochondrial antibody: A neglected entity needing reappraisal 16
Panel discussion 16
La ribavirina nell'epatite cronica C: storia e segreti di un grande successo 16
Prospective study on the prevalence of HCV infection in consecutive adult inpatients in a hospital division of Internal Medicine in Tuscany 15
The role of gut microbiota in chronic liver diseases 12
null 10
Totale 5.809
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.339
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.368 185 42 65 189 94 128 135 171 127 111 47 74
2020/2021922 33 109 28 122 88 95 41 152 31 107 46 70
2021/2022750 45 68 44 54 28 26 37 37 41 78 92 200
2022/20231.021 89 90 124 158 90 237 10 78 83 4 32 26
2023/2024910 63 57 94 103 43 187 232 17 6 33 16 59
2024/202513 13 0 0 0 0 0 0 0 0 0 0 0
Totale 5.809